2018-03-28                     Senate Journal                      Page 2410
HB 43                                                                                                                         
The Judiciary Committee considered CS FOR HOUSE BILL                                                                            
NO. 43(JUD) "An Act relating to prescribing, dispensing, and                                                                    
administering an investigational drug, biological product, or device by                                                         
physicians for patients who are terminally ill for the purpose of                                                               
sustaining the patient's life; providing immunity related to                                                                    
manufacturing, distributing, or providing investigational drugs,                                                                
biological products, or devices; and relating to licensed health care                                                           
facility requirements." Signing do pass: Senator Coghill, Chair;                                                                
Senator Wielechowski. Signing no recommendation: Senators                                                                       
Costello, Kelly, Shower.                                                                                                        
                                                                                                                                
The following previously published fiscal information applies:                                                                  
          Fiscal Note No. 2, zero, Department of Commerce, Community                                                           
      and Economic Development                                                                                                  
                                                                                                                                
The bill was referred to the Rules Committee.